Moreover, TSAIII demonstrates significant antimetastatic activity against renal cell carcinoma cells through the inhibition of cathepsin C expression at the AKT/miR-129-5p axis [40]. This evidence concerns the gene AKT1 and hereditary clear cell renal cell carcinoma.